Literature DB >> 21822221

E. coli crisis opens door for Alexion drug trial.

Lucas Laursen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21822221     DOI： 10.1038/nbt0811-671

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  Eculizumab in severe Shiga-toxin-associated HUS.

Authors:  Anne-Laure Lapeyraque; Michal Malina; Véronique Fremeaux-Bacchi; Tobias Boppel; Michael Kirschfink; Mehdi Oualha; François Proulx; Marie-José Clermont; Françoise Le Deist; Patrick Niaudet; Franz Schaefer
Journal:  N Engl J Med       Date:  2011-05-25       Impact factor: 91.245
  1 in total
  2 in total

1.  Novel antimicrobial peptide prevents C. rodentium infection in C57BL/6 mice by enhancing acid-induced pathogen killing.

Authors:  Tracy Lackraj; Kathene Johnson-Henry; Philip M Sherman; Steve D Goodman; Anca M Segall; Debora Barnett Foster
Journal:  Microbiology       Date:  2016-07-13       Impact factor: 2.777

2.  Progress and Trends in Complement Therapeutics.

Authors:  Daniel Ricklin; John D Lambris
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.